Biotechnology

Monday Jun 14, 2021 - 9:00 am

Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

HYEX’s portfolio of wholly owned subsidiaries currently comprises BergametNA and Ultimate Brain NutrientsBergametNA, whose products target cardiovascular and immune health, sources its formulations from the Citrus Bergamot SuperFruit(TM)The bergamot fruit is richly packed with polyphenolic flavanones, which are known to decrease bad cholesterol, triglyceride, and glucose, as well as increase the good cholesterolBergaMet only uses the highest concentration of polyphenolic flavanones (“BPF”) as the higher…

Friday Jun 11, 2021 - 9:00 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Sponsor Kernel Flow, Ketamine Feasibility Study

Feasibility study is designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamicsCybin, Kernel working together to leverage proprietary Kernel Flow device for psychedelic-based studies and clinical trialsKetamine is a dissociative injected anesthetic that blocks sensory perception Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced a key step forward in its focus on progressing psychedelic therapeutics. The company will be sponsoring a feasibility study of the…

Friday Jun 11, 2021 - 9:00 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) on Course for Private Demonstrations of the i/Blue Imaging System(TM) at the American Urological Association Annual Conference in September

Further refinement of if the i/Blue Imaging System will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems as well as feedback from preliminary meetings with the FDABladder cancer is anticipated to cause over 1,000,000 physician consultations per year, resulting in $4 billion in total costs for bladder cancer treatment and managementImagin Medical plans to complete its proprietary i/Blue…

Thursday Jun 10, 2021 - 10:44 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright’s Upcoming Virtual Psychedelics Conference

Tryp Therapeutics’ Chairman and CEO Greg McKee will present at the virtual Psychedelics in Psychiatry and Beyond Conference planned for Thursday, June 17, 2021As part of his presentation, McKee will discuss Tryp’s business and its pipeline, which includes its proprietary psilocybin-centered drug development programTryp will present alongside other pharmaceutical companies leading research in psychedelic-assisted therapeutics Psychedelics have increasingly drawn the attention of different players and…

Thursday Jun 10, 2021 - 9:51 am

Brain Scientific Inc. (BRSF) Poised to Offer Brain Monitoring Solution as Research Shows Neurological Findings in COVID-19 Long-Haulers

Most extensive research to date reports significant neurological problems in patients who suffered from so-called long-haul COVID-19Neurological issues range from mild to more severe such as cognitive impairment, which affects around 20% of these patientsBRSF appears poised to be part of the solution as long-haulers need monitoring so that doctors can assess if they have neurological disorders The neurological and psychiatric aftermath of COVID-19 has…

Thursday Jun 10, 2021 - 9:00 am

RYAH Group Inc. (CSE: RYAH) Reports on the Medical Benefits of the “Munchies”

Reported on the therapeutic benefit of munchies for nausea and vomitingRecorded over 14,500 sessions from patients seeking relief from nausea Munchies are a medical benefit for those going through chemotherapy or diagnosed with cachexia, also known as a wasting disorder RYAH Group (CSE: RYAH), the leading data technology company in plant-based medicine, collects data through its IoT dose-measuring devices and AI analytics. Recently the company reported…

Tuesday Jun 08, 2021 - 9:30 am

Brain Scientific Inc.’s (BRSF) Marketing Director Interviewed for One of Top News Source for Startups

Irina Nazarova, Brain Scientific’s marketing director, interviewed for Grit Daily, one of the top news hubs for startups, discussing exciting new product developments the company is working onBRSF is poised to extend the universe of EEG use cases, expanding possible markets for its disruptive products Irina Nazarova, marketing director of Brain Scientific (OTCQB: BRSF), was interviewed for Grit Daily News, the top news source on…

Tuesday Jun 08, 2021 - 9:15 am

United Medical Equipment Business Solutions Network Inc. Stands Out As Trusted Supplier of Life Saving Personal Protective Equipment

With demand for PPE exploding virtually overnight due to the pandemic, PPE-related fraud involving counterfeit or faulty equipment surgedAs a reliable source of everything PPE-related, UME has established itself as a go-to provider of premier equipment that can be trusted The company pivoted its business model when the pandemic started to seize growing market opportunity and provide reliable, high-quality PPE essentials amid the virus outbreak United Medical Equipment Business Solutions Network…

Friday Jun 04, 2021 - 9:15 am

Brain Scientific Inc. (BRSF) Poised to Solve Major Obstacles to Neurological Testing in Pediatric Patients

There is a significant need for EEG diagnostics in pediatric patients, but traditional testing is challenging due to poorly fitting adult-sized equipment, which also increases resistance to testingThis leaves a considerable gap in neurological care for young patientsBRSF’s Pediatric NeuroCap steps in to solve major barriers limiting EEG monitoring in pediatric care There is a significant need for EEG diagnostics in pediatric patients, as children…

Thursday Jun 03, 2021 - 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

Psychedelics have been on the receiving end of groundbreaking research, which have greatly influenced the medical acceptance of the compoundsPharmaceutical developer Tryp Therapeutics is looking to use existing preclinical and clinical data to proceed directly to Phase 2a clinical trialsThe company intends to contribute to the growing body of research through academic collaborations with leading American institutions The research will focus on indications that other pharmaceutical…

Wednesday Jun 02, 2021 - 9:30 am

Healthy Extracts Inc. (HYEX) Using HERHEART(TM) Supplement to Address the Cardiovascular Disease Headache among Women

Cardiovascular disease is the leading cause of mortality among women globally and in the USUsing this knowledge as the motivation, Healthy Extracts, through its wholly owned subsidiary BergaMet NA, developed HERHEART(TM)HERHEART is derived from the bergamot fruit, richly packed with polyphenols, and is formulated specifically for women to improve heart health and perimenopausal symptomsPolyphenols have antioxidant and anti-inflammatory properties and are associated with improved heart…

Wednesday Jun 02, 2021 - 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Beginning 2021 Strong with New Drugs and Life Sciences Advancements

Promising results have been recorded in the first pilot study of a Rotigotine skin patch for Parkinson’s patientsWholly owned subsidiary Vektor is reaching a major milestone in the development of Rotigotine with the potential for a pivotal human trialThe company is planning the construction of a new lab and manufacturing space up to 32,000 square feet in Biberach, GermanyPilot project involving rapid COVID-19 PCR tests…

Friday May 28, 2021 - 12:17 pm

DGE’s 2-Day Omnichannel Marketing Strategy Symposium To Offer Skills To Elevate Customized Consumer Experience

Live Streaming Event June 10th-11th 2021 On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical,…

Friday May 28, 2021 - 11:33 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Building Psychedelic Medicine Program on Foundation of Strong Leadership, Pharmaceutical Alliances

Pharmaceutical developer Tryp Therapeutics is focused on producing novel bioscience solutions for conditions with unmet needsTryp’s current flagship program involves development of a synthetic psychedelic drug candidate for treating specific pain and eating disorder indicationsThe company expects to begin manufacturing its initial oral psilocybin formulation in September 2021Tryp’s scientific and executive team has decades of experience in large pharma, emerging pharma, drug approvals, psychedelics and…

Friday May 28, 2021 - 9:00 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Highlights, Q1 Financials Herald Bright Horizon for Company

POAI announced that total stockholders’ equity increased by nearly $33 million to $35.5 millionFinancial report notes net proceeds of $35.6 million from private placement, direct offering, warrant exercisesCompany subsidiaries reached several milestone achievements throughout the quarter. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, reported its financial results for first quarter 2021, the period…

Wednesday May 26, 2021 - 9:00 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Files Patent Designed to Bolster IP Psychedelic Molecule, Delivery Mechanism Portfolio

Company files 12th patent to strengthen proprietary IP programCybin believes treatments can decrease costs, increase access to important therapeuticsPatent provides wide range of benefits in Cybin’s four drug candidate program Cybin (NEO: CYBN) (OTCQB: CLXPF) has filed a new provisional patent application designed to strengthen the company’s ongoing drug candidate programs (https://ibn.fm/9V5sv). Cybin, a biotechnology company focused on progressing psychedelic therapeutics, is focused on expanding…

Tuesday May 25, 2021 - 10:34 am

GBM Brain Cancer Sorting Development Latest Bit of Good News for Patients as CNS Pharmaceuticals (NASDAQ: CNSP) Develops Drug Trial

Biopharmaceutical developer CNS Pharmaceuticals is working on ways to improve overall survivability for glioblastoma multiforme (“GBM”) brain cancer patientsGBM is considered to be an incurable brain cancer that usually only leaves patients about 15 months to live once they are diagnosed, prompting research efforts to improve patients’ responses to therapeutic approachesA recent study found that the GBM patients most likely to succumb within a relatively…

Tuesday May 25, 2021 - 9:17 am

Brain Scientific Inc. (BRSF) May Provide Diagnostics Solutions for Sports Concussions as They Become Growing Public Health Problem

Sports concussions on the rise; with more children playing sports, it is becoming an important public health problemQuantitative EEG shows promise in identifying athletes with post-concussion impairments; for this, reusable EEG caps and mobile-based applications are helpfulBRSF provides portable EEG devices that bring brain diagnostics to settings where it was previously impossible including off-site testing within sports A recent article published by Brain Scientific (OTCQB:…

Monday May 24, 2021 - 1:50 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Upcoming Drug Candidate Trial Rides Swell of Groundbreaking Psychedelic Medicine Efforts

Tryp Therapeutics is a pharmaceutical company focused on developing new potential treatments for medical conditions with unmet needsThe company’s current lead candidates for drug development are a synthetic psychedelic for treating fibromyalgia and eating disordersTryp’s efforts to develop a psychedelic drug candidate are part of a broader scientific movement to use various mind-altering drugs to treat select neurological conditions when paired with the care of…

Friday May 21, 2021 - 9:15 am

Brain Scientific Inc. (BRSF) Committed to Expand Access to Neurological Care for Infected Patients Amid the Pandemic

Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoringBrain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to virus transmission riskBRSF's sanitary disposable NeuroCap(TM) helps health care workers get quick, reliable insights into patient's condition while minimizing cross-contamination risk Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company providing next-gen…

Thursday May 20, 2021 - 9:15 am

Hero Technologies Inc. (HENC) Receives Confirmation of Value of Veteran Hemp Acquisition

Company pleased that independent review has confirmed fair value of Veteran Hemp Co. asset acquisitionHENC entered into purchase agreement to acquire all assets of Veteran Hemp Co. in November 2020Hero Technologies CEO noted that "acquisition is in line with our company's growth strategy of adding accretive assets to our portfolio” Hero Technologies (OTC: HENC), a cannabis company focused on a vertically integrated strategy, has received an…

Thursday May 20, 2021 - 9:00 am

Brain Scientific Inc. (BRSF) Offers Solutions for COVID-19 EEG Accessibility

Seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures Due to a shortage of PPE and limited contact, EEG accessibility was limited during the pandemicThe NeuroCap can fill the gap in EEG accessibility during the pandemic and into the future, as more long-term studies are created Brain Scientific (OTCQB: BRSF) is developing innovative and proprietary medical…

Tuesday May 18, 2021 - 1:47 pm

RYAH Group, Inc. (CSE: RYAH) Enters New Zealand Market

A partnership with Medical Kiwi LTD makes it possible for RYAH to enter the New Zealand MarketMedical Kiwi was the first South Island-based company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivateThe potential market for medical cannabis in New Zealand is at NZ$1.5 billion RYAH Group (CSE: RYAH), a health care analytics and technology company, has entered the New…

Tuesday May 18, 2021 - 1:31 pm

Predictive Oncology Inc. (NASDAQ: POAI) Appoints Venture Investor Dr. Christina Jenkins to Board of Directors

POAI appoints strategic advisor, venture investor Dr. Christina Jenkins to board of directorsDr. Jenkins’ experience spans work in capital markets, clinical medicine, public healthcare systems Other roles include current Board Director for Independence Health Group, Venture Partner at Phoenix Venture Partners, Board Observer for Madorra Inc., board advisory roles at multiple value-generating healthcare companies Past experience includes role as founding CEO of OneCity Health Services, subsidiary of…

Tuesday May 18, 2021 - 1:03 pm

Brain Scientific Inc. (BRSF) Featured in Med-Tech News as Technology Provider Revolutionizing Pediatric Brain Diagnostics

BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes.The need for brain diagnostics in children is on the rise, but supply and availability of EEG testing to pediatric physicians remains limited.BRSF has stepped in to fill the gap in unmet patients' needs; positioning itself as a leading innovator in…

Tuesday May 18, 2021 - 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel

XPhyto recently delivered 2,000 of its rapid Covid-ID Lab test kits to an established Israeli distributor for clinical evaluation by the Ministry of HealthThe delivery, which marks entry into the Middle East, follows the approval of the test kits in EuropeIn an earlier interview, CEO Hugh Rogers had noted that XPhyto was looking to expand distribution to various markets, including the Middle East In an…

Tuesday May 18, 2021 - 9:00 am

Healthy Extracts Inc. (HYEX) Is Well-Positioned To Capitalize The Growing Demand Of The Nutraceuticals Products Market

Healthy Extracts Inc. through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on building a stronghold in the nutraceuticals marketBergaMet NA is the only company authorized to manufacture, distribute, and sell Citrus Bergamot SuperFruit(TM) in North America, a supplement enriched with the world’s best quality polyphenols and flavonoidsBergaMet North America’s HERHEART(TM) is a natural supplement, scientifically formulated to support woman’s cardiovascular…

Monday May 17, 2021 - 9:00 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology, will Potentially Reduce High Bladder Cancer Recurrence Rates

Approximately 50% of patients who have bladder cancer will see a recurrence of the condition – often due to poor margin visibilityWhite light has been the standard procedure during cystoscopies, but is only beneficial if tumors protrude from the bladder wallBlue light cystoscopies address this issue, increasing the odds of removing more cancerous cells and reducing the recurrence of the cancerThe i/Blue Imaging System(TM) improves…

Friday May 14, 2021 - 12:29 pm

RYAH Group Inc. (CSE: RYAH) Releases “April 2021 Patients Patterns in New York Report” to Provide Data-Driven Insights Amid Latest Legislation Change

RYAH has released April 2021 Patients Patterns in New York Report to bring invaluable data-driven insights within the plant-based health industry amid recent recreational cannabis legislation change in this state.The company leveraged data from 4,387 New York patients within the RYAH Data ecosystem to discover New York-based patients' profiles, including their preferences and medical reasons for use.As an authority in dose-control technology for plant-based medicine,…

Friday May 14, 2021 - 12:07 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Maintains Buy Rating in Recent Equity Update

April analyst reports all point to a bright future for Cybin“CYBN is a true multi-molecule company that's not being reflected in its valuation,” reports Stifel“With a relatively small 5% penetration, Cybin could achieve ~$8B in sales in the U.S. and EU5 combined,” notes Roth A series of recent analyst reports bodes well for Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing…

Thursday May 13, 2021 - 1:23 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working Towards a Better Future for Bladder Cancer Patients

Bladder cancer is still the sixth most prevalent cancer in the U.S. in 2021The total number of new bladder cancer cases is expected to reach 83,730, with deaths totaling 17,200 this yearImagin Medical Inc. is hoping to offer a better standard of care for bladder cancer patients with its i/Blue Imaging System(TM) that improves visualization for resection, potentially lowering recurrence rates According to American Cancer…

Thursday May 13, 2021 - 12:06 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Builds Alliances Ahead of Psychedelic Drug Trial for Eating Disorders

Orphan-stage pharmaceutical innovator Tryp Therapeutics is dedicated to developing novel therapies for medical conditions with unmet needsTryp’s embrace of psychedelic drug potential is demonstrated in its advancing clinical trials seeking an answer to eating disorders such as binge eating and hyperphagiaThe company is also developing a clinical trial to address the needs of fibromyalgia patients who often rely on opioids to relieve their symptomsTryp has…

Wednesday May 12, 2021 - 11:36 am

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) i/Blue Imaging System(TM) on Schedule for Completion in 2022

Imagin Medical’s contract manufacturer, Lighthouse Imaging, has developed a program focused on refining the i/Blue System’s design for manufacturingLighthouse’s manufacturing process will ensure that regulatory standards are followed while maintaining optimal performance and staying within targeted costsImagin is currently focusing on using the i/Blue system for bladder cancer visualization with plans to extend the use of the technology to other procedures in the future Imagin…

Wednesday May 12, 2021 - 11:17 am

Healthy Extracts Inc. (HYEX) Announces Association Of Dr. Kahn With The Healthy Extracts Inc. Medical Board

Healthy Extracts Inc. announces the addition of Dr. Joel Kahn, M.D., a world-renowned, triple board-certified cardiology specialist to its medical boardDr. Kahn has personally conducted clinical studies that confirm the benefits of Citrus Bergamot SuperFruit(TM) for cardiovascular healthCitrus Bergamot SuperFruit(TM), the main ingredient in BergametNA’s product line, is the super fruit alternative to prescribed cholesterol medications Healthy Extracts (OTCQB: HYEX), through its developing and acquiring complementary…

Tuesday May 11, 2021 - 2:41 pm

Brain Scientific Inc. (BRSF) Releases 2020 Financial, Business Results

BRSF made strides on operations front to improve lead times, quality controlCompany experienced revenue growth, increase in assets and R&DBrain Scientific has identified that only 30% of U.S. hospitals have equipment for routine EEGs due to cost and space constraints Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, announced it has filed its annual report for the fiscal year that ended Dec. 31, 2020 (https://ibn.fm/GCazt). The…

Tuesday May 11, 2021 - 2:27 pm

United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App

Simple design enables consumers to prevent medication errorsOffers 12 different functionalities with the newest addition of GoodRXNow offering up to 85% discount on most medications at over 70,000 pharmacies Across the United States. Powered by GoodRXDownload the APP now and not only manage your medication but save money every time you walk into your local Pharmacy by having your coupons ready United Medical Equipment Business…

Tuesday May 11, 2021 - 2:11 pm

Predictive Oncology’s (NASDAQ: POAI) C-Level Leaders Provide Company, Operations Update on New Podcast

Bell2Bell podcast features company CEO, CFO, CTO of Helomics subsidiaryPOAI is “in probably the best situation we’ve been in since the existence of the company,” reports CFOCompany anticipates revenue from its unique PeDAL platform Three Predictive Oncology (NASDAQ: POAI) executives were featured guests on a recent Bell2Bell podcast (https://ibn.fm/DumLs). Newly appointed CEO Mel Engle, CFO Bob Myers and Mark Collins, chief technical officer of the…

Monday May 10, 2021 - 2:28 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) on Track to Begin Potentially Pivotal Phase 2 GBM Trial This Quarter for Berubicin

During Phase 1 trials, Berubicin showed 44% of patients experienced a clinical benefit of stable disease or better, one being cancer-free after 14 years, and two patients reporting significant tumor reduction (up to 80%)Additional research to be conducted by sublicensee partner WPD Pharmaceuticals, Inc. in Poland, including the first-ever pediatric trialThe glioblastoma multiforme (“GBM”) treatment market is expected to reach $1.4 billion by 2027CNS Pharma…

Monday May 10, 2021 - 12:56 pm

Brain Scientific Inc. (BRSF) Receives First Purchase Order from Department of Veterans Affairs

First order marks a significant milestone as Veterans Affairs runs the largest integrated healthcare system in the countryBRSF hopes the relationship will bring cutting-edge brain diagnostics to a nationwide network of veterans’ health care Brain Scientific (OTCQB: BRSF), a commercial-stage, neurology-focused medical device and software company, has announced the start of working with the U.S. Department of Veterans Affairs – VA Medical Centers, which placed the first purchase order of NeuroCap(TM) for one of its hospitals (https://ibn.fm/p3rw0). This…

Monday May 10, 2021 - 12:19 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Looks to New Senior Management with Expertise in Development, Clinical Capabilities

Company committed to building presence in U.S. and Europe to advance mission of improving mental health careNew appointments will strengthen Cybin’s development and clinical operations globally, solidify position within the industryNew leaders bring broad experience, deep insight to their new roles Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing psychedelic therapeutics, recently made key senior-management changes designed to provide the company…

Articles

Articles Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions